Cost‐effectiveness analysis of delgocitinib in adult patients with atopic dermatitis in Japan

• Egile Nagusiak: Motoi Takenaka (Egilea), Mai Matsumoto (Egilea), Hiroyuki Murota (Egilea), Sachie Inoue (Egilea), Hidetoshi Shibahara (Egilea), Kazufumi Yoshida (Egilea), Sotaro Takigawa (Egilea), Atsushi Ishimoto (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2021-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Objectives This study evaluated the cost‐effectiveness of delgocitinib relative to moisturization therapy in adult patients with moderate to severe atopic dermatitis. Methods The analysis was performed by using the simulation model with the patient‐level data from a phase 3 study and its lo...